The same group further observed that transplanted p53/MCA sarcomas in mice were cured by the synergistic effects of RT and anti-PD-1 antibody, whereas identical treatment failed in autochthonous sarcomas, which exhibited immunoediting, reduced neoantigen expression, and tumor-specific immune tolerance [50]. The gene discussed is TP53; the disease is sarcoma.